Salt sensitivity: A consequence of the metabolic syndrome?

Journal of Hypertension

Volumn 24, Issue 8, 2006, Pages 1475-1477

  Melander, Olle ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHANNEL; UBIQUITIN PROTEIN LIGASE NEDD4;

BLOOD PRESSURE; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY TUBULE ABSORPTION; METABOLIC SYNDROME X; NOTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SALT INTAKE; SODIUM ABSORPTION; SODIUM RESTRICTION;

EID: 33746772114     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000239280.89819.bc     Document Type: Note

References (38)

1. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004; 93:136-141.
2. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110:1245-1250.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-2716.
4. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366:1059-1062.
5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
6. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15:539-553.
7. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16:442-443.
8. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
9. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998; 279:1383-1391.
10. He FJ,MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16:761-770.
11. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10.
12. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8:II127-II134.
13. Sharma AM, Schorr U. Salt sensitivity and insulin resistance: is there a link? Blood Press Suppl 1996; 5:59-63.
14. Skrabal F, Hamberger L, Ledochowski M. Inherited salt sensitivity in normotensive humans as a cause of essential hypertension: a new concept. J Cardiovasc Pharmacol 1984; 6 (Suppl. 1):S215-S223.
15. Endre T, Mattiasson I, Hulthén UL, Lindgärde F, Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens 1994; 12:81-88.
16. Zavaroni I, Coruzzi P, Bonini L, Mossini GL, Musiari L, Gasparini V, et al. Association between salt sensitivity and insulin concentrations in patients with hypertension. Am J Hypertens 1995; 8:855-858.
17. Sharma AM, Ruland K, Spies KP, Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 1991; 9:329-335.
18. Sharma AM, Schorr U, Distler A. Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 1993; 21:273-279.
19. Fuenmayor N, Moreira E, Cubeddu LX. Salt sensitivity is associated with insulin resistance in essential hypertension. Am J Hypertens 1998; 4:397-402.
20. Galletti F, Strazzullo P, Ferrara I, Annuzzi G, Rivellese AA, Gatto S, et al. NaCl sensitivity of essential hypertensive patients is related to insulin resistance. J Hypertens 1997; 15:1485-1491.
21. Melander O, Groop L, Hulthen UL. The effect of salt on insulin sensitivity differs according to gender and degree of salt sensitivity. Hypertension 2000; 35:827-831.
22. Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertensive patients with metabolic syndrome. J Hypertens 2006; 24:1626-1632.
23. Fava C, Burri P, Almgren P, Groop L, Hulthen UL, Melander O. Heritability of ambulatory and office blood pressure phenotypes in Swedish families. J Hypertens 2004; 22:1717-1721.
24. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 1986; 39:809-821.
25. Shimkets RA, Warnock DG, Bositis CM, Nelson Williams C, Hansson JH, Schambelan M, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79:407-414.
26. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 1995; 10:394-399.
27. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, et al. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355:262-265.
28. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289:119-123.
29. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A 2003; 100:680-684.
30. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107-1112.
31. Harvey KF, Dinudom A, Cook DI, Kumar S. The Nedd4-like protein KIAA0439 is a potential regulator of the epithelial sodium channel. J Biol Chem 2001; 276:8597-8601.
32. Kamynina E, Debonneville C, Bens M, Vandewalle A, Staub O. A novel mouse Nedd4 protein suppresses the activity of the epithelial Na+channel. FASEB J 2001; 15:204-214.
33. Melander O, Orho M, Fagerudd J, Bengtsson K, Groop PH, Mattiasson I, et al. Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension. Hypertension 1998; 31:1118-1124.
34. Pearce D. The role of SGK1 in hormone-regulated sodium transport. Trends Endocrinol Metab 2001; 12:341-347.
35. Endre T, Mattiasson I, Berglund G, Hulthen UL. Insulin and renal sodium retention in hypertension-prone men. Hypertension 1994; 23:313-319.
36. Reaven GM. The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 1997; 30:928-931.
37. von Wowern F, Berglund G, Carlson J, Mansson H, Hedblad B, Melander O. Genetic variance of SGK-1 is associated with blood pressure, blood pressure change over time and strength of the insulin-diastolic blood pressure relationship. Kidney Int 2005; 68:2164-2172.
38. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial. Lancet 2005; 366:1279-1289.